Stockreport

BioTime Announces Appointment of General Counsel

BlackRock Technology and Private Equity Term Trust Common Shares of Beneficial Interest  (BTX) 
NASDAQ:AMEX Investor Relations: biotimeinc.com/pexservice/investors
PDF ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company developing cellular therapies for un [Read more]